Literature DB >> 3315695

A phase II study of carboplatin in advanced or metastatic stomach cancer.

M Beer1, F Cavalli, S B Kaye, L M Lev, M Clavel, J Smyth, M van Glabbeke, J Renard, H M Pinedo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315695     DOI: 10.1016/0277-5379(87)90101-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


× No keyword cloud information.
  5 in total

Review 1.  Second-line chemotherapy for advanced gastric cancer in Korea.

Authors:  Sun Kyung Baek; Si-Young Kim; Jae-heon Jeong; Kyung San Cho; Hwi-Joong Yoon
Journal:  Gastric Cancer       Date:  2012-03-13       Impact factor: 7.370

2.  Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.

Authors:  Thomas Makatsoris; Pavlos Papakostas; Haralabos P Kalofonos; Ioannis Xanthakis; Dimitrios Tsavdaridis; Gerasimos Aravantinos; Helen Gogas; George Klouvas; Paris Kosmidis; Dimitrios Pectasides; George Fountzilas
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 3.  Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.

Authors:  A J Wagstaff; A Ward; P Benfield; R C Heel
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

4.  Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells.

Authors:  T Kusumoto; Y Maehara; H Baba; I Takahashi; H Kusumoto; S Ohno; K Sugimachi
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

5.  A case of gastric adenocarcinoma in a Shih Tzu dog: successful treatment of early gastric cancer.

Authors:  Hee-Chun Lee; Ji-Hyun Kim; Cho-Hee Jee; Jae-Hoon Lee; Jong-Hyun Moon; Na-Hyun Kim; Jung-Hyang Sur; Kyu-Woan Cho; Byeong-Teck Kang; Jeongim Ha; Dong-In Jung
Journal:  J Vet Med Sci       Date:  2014-03-20       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.